8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.
2011 / Randomized controlled comparative trial
A randomized trial evaluated a self-help book focused on cognitive behavioral therapy for insomnia against standard sleep hygiene advice, with follow-up after 3 months and an 81.9% response rate. The self-help book resulted in significantly better scores on sleep questionnaires compared to sleep hygiene advice. Compared to pre-treatment, the self-help book improved sleep scores (effect sizes 0.61-0.62) and depression scores (effect size 0.18), while reducing the proportion using sleep medications. Sleep hygiene advice improved scores on some sleep scales (effect sizes 0.24-0.28) but worsened another (effect size -0.36), and increased the proportion using sleep medications as well as days per week taking them (effect size -0.50).
Bjorvatn B, Fiske E, Pallesen S Scand J Psychol, 2011. PMID 21790620
2011 / Experimental fMRI study with hyperinsulinemic clamp
Researchers investigated whether circulating glucose levels influence brain regions regulating the motivation to consume high-calorie foods using functional MRI (fMRI) combined with a stepped hyperinsulinemic euglycemic-hypoglycemic clamp. Mild hypoglycemia preferentially activated limbic-striatal regions in response to food cues and produced a greater desire for high-calorie foods. Conversely, euglycemia preferentially activated the medial prefrontal cortex and reduced interest in food stimuli. Higher circulating glucose predicted greater medial prefrontal cortex activation, but this response was absent in obese subjects.
Page KA, Seo D, Belfort-DeAguiar R, et al. J Clin Invest, 2011. PMID 21926468
2011 / Randomized controlled trial
Forty-seven overweight or obese women (mean BMI = 31.2) were randomized to a 4-month mindfulness intervention for stress eating or a waitlist control group. Participants in the intervention group showed improvements in mindfulness, anxiety, and external-based eating compared to controls. Across the whole sample, the groups did not differ in average cortisol awakening response (CAR), weight, or abdominal fat over time. However, obese treatment participants demonstrated significant CAR reductions and maintained body weight, whereas obese controls had stable CAR and gained weight. Additionally, improvements in mindfulness, chronic stress, and CAR correlated with decreases in abdominal fat.
Daubenmier J, Kristeller J, Hecht FM, et al. J Obes, 2011. PMID 21977314
2011 / Randomized controlled trial
In this randomized clinical trial sub-analysis, 243 participants were assigned to a control low-fat diet, a Mediterranean diet with virgin olive oil, or one with nuts for three years. Plasma BDNF levels showed non-significant increases in both Mediterranean diet groups, but participants receiving nuts had lower odds of low BDNF levels below 13 µg/ml (OR 0.22; 95% CI 0.05-0.90). Among participants with baseline depression, BDNF levels were significantly higher in the nut-supplemented group.
NANO counterpoint →
Sánchez-Villegas A, Galbete C, Martinez-González MA, et al. Nutr Neurosci, 2011. PMID 22005283
2011 / Controlled clinical trial
A controlled clinical trial assigned 81 undergraduate students with mild to moderate depression, anxiety, or stress to integrated yoga, yoga as exercise, or a control group. Over time, participants in both yoga groups experienced decreased depression and stress, an increased sense of hopefulness, and increased flexibility compared to controls. However, only the integrated yoga group experienced decreased anxiety-related symptoms and decreased salivary cortisol from the beginning to the end of the study.
Smith JA, Greer T, Sheets T, et al. Altern Ther Health Med, 2011. PMID 22164809
2010 / Randomized controlled trial
In a 22-week randomized trial involving 54 community-dwelling adults aged 55 or older with mild-to-moderate Alzheimer's disease, 30 mg daily of saffron showed similar efficacy to 10 mg daily of donepezil. Cognitive subscale and clinical dementia rating scores were the primary outcomes. Overall adverse events occurred at similar rates, although vomiting was significantly more frequent in participants receiving donepezil.
Akhondzadeh S, Shafiee Sabet M, Harirchian MH, et al. Psychopharmacology (Berl), 2010. PMID 19838862
2010 / Randomized crossover trial
In a double-blind crossover trial, 30 healthy adults drank beverages with 520 mg or 994 mg of cocoa flavanols or a matched control. Both doses significantly enhanced Serial Threes subtraction performance over one hour of testing. The 994 mg dose accelerated visual information processing responses but increased Serial Sevens calculation errors, whereas only the 520 mg dose significantly blunted self-reported mental fatigue.
Scholey AB, French SJ, Morris PJ, et al. J Psychopharmacol, 2010. PMID 19942640
2010 / Randomized controlled trial
In a randomized, double-blind, placebo-controlled trial, 12 older adults with early memory decline consumed Concord grape juice or placebo for 12 weeks. Grape juice supplementation significantly improved verbal learning, with non-significant enhancements in verbal and spatial recall. No effects were observed on depressive symptoms, body weight, or waist circumference, though fasting insulin increased slightly.
Krikorian R, Nash TA, Shidler MD, et al. Br J Nutr, 2010. PMID 20028599
2010 / Intervention trial with companion matched control comparison
This study investigated the effects of daily consumption of wild blueberry juice in nine older adults with early memory changes over 12 weeks. Participants demonstrated improved paired associate learning (p = 0.009) and word list recall (p = 0.04), alongside trends toward reduced depressive symptoms (p = 0.08) and lower glucose levels (p = 0.10). When compared with a demographically matched sample consuming a placebo berry beverage in a companion trial, comparable results were seen for paired associate learning.
Krikorian R, Shidler MD, Nash TA, et al. J Agric Food Chem, 2010. PMID 20047325
2010 / Pseudo-randomized, double-blinded, placebo-controlled crossover trial
A 30-day crossover trial evaluated the effect of phased caffeine withdrawal and abstinence versus maintenance in 66 regular caffeine consumers with tinnitus. Caffeine had no effect on tinnitus severity, with a mean difference between caffeinated and decaffeinated days of -0.04 (95% CI -1.99 to 1.93, p=0.97). Significant acute adverse symptoms of caffeine withdrawal were observed. The authors found no evidence to justify caffeine abstinence to alleviate tinnitus, noting that acute withdrawal effects might add to the tinnitus burden.
Claire LS, Stothart G, McKenna L, et al. Int J Audiol, 2010. PMID 20053154
2010 / Randomized controlled trial
A randomized trial evaluated 3 months of aerobic cycling versus table football in male patients with chronic schizophrenia and healthy subjects. Relative hippocampal volume increased by 12% in exercising patients and 16% in exercising healthy controls, while nonexercising patients saw a 1% decrease. Volume changes correlated with aerobic fitness gains (r = 0.71; P = .003) and short-term memory improvement (r = 0.51; P < .05).
Pajonk FG, Wobrock T, Gruber O, et al. Arch Gen Psychiatry, 2010. PMID 20124113
2010 / Double-masked randomized controlled trial
Researchers conducted a double-masked randomized trial evaluating 343 healthy term infants assigned to infant formulas with 0% DHA (control), 0.32% DHA, 0.64% DHA, or 0.96% DHA (all supplemented formulas also included 0.64% arachidonic acid). Infants fed the control formula had significantly poorer visual evoked potential visual acuity at 12 months of age compared to those receiving any DHA-supplemented formula (P < 0.001). No significant differences in visual acuity were observed among the 3 amounts of DHA supplementation at either site or any age tested.
Birch EE, Carlson SE, Hoffman DR, et al. Am J Clin Nutr, 2010. PMID 20130095
2010 / Open-label clinical trial
In an open-label pilot study, 21 institutionalized individuals with moderate-to-severe Alzheimer's disease consumed two 4-oz glasses of apple juice daily for 1 month. Participants showed no change in the Dementia Rating Scale or ADCS-Activities of Daily Living. However, caregivers reported an approximate 27% (P < .01) improvement in behavioral and psychotic symptoms on the Neuropsychiatric Inventory, with the largest changes observed in anxiety, agitation, and delusion.
Remington R, Chan A, Lepore A, et al. Am J Alzheimers Dis Other Demen, 2010. PMID 20338990
2010 / Randomized controlled trial
A randomized trial assigned 72 Danish children with autism spectrum disorders aged 4 to 10 years to a gluten- and casein-free diet or an unrestricted diet. At 12 months, evaluations of 26 diet-group participants and 29 controls revealed significant improvements in autism behaviors and hyperactivity scores. Group improvements were sustained through 24 months, although the absence of a placebo limits determining whether non-dietary factors contributed.
Whiteley P, Haracopos D, Knivsberg AM, et al. Nutr Neurosci, 2010. PMID 20406576
2010 / Randomized crossover trial
A randomized, double-blind crossover pilot trial evaluated 2 weeks of a tart cherry juice blend versus placebo in 15 older adults with chronic insomnia. Tart cherry juice significantly decreased minutes awake after sleep onset compared with placebo. However, it did not significantly improve sleep latency, total sleep time, or sleep efficiency relative to placebo, with overall effect sizes characterized as moderate to negligible.
Pigeon WR, Carr M, Gorman C, et al. J Med Food, 2010. PMID 20438325
2010 / Clinical trial
Researchers evaluated the effect of consuming seven different Jerte Valley cherry cultivars on the sleep-wake cycle, 6-sulfatoxymelatonin levels, and urinary total antioxidant capacity in middle-aged and elderly participants. Nocturnal activity and rest were measured by actigraphic monitoring. Intake of each cherry cultivar led to beneficial effects on actual sleep time, total nocturnal activity, assumed sleep, and immobility. Significant increases in urinary 6-sulfatoxymelatonin levels and total antioxidant capacity were also observed after intake of each cultivar.
Garrido M, Paredes SD, Cubero J, et al. J Gerontol A Biol Sci Med Sci, 2010. PMID 20547498
2010 / Randomized controlled trial
In a 16-week randomized, double-blind, placebo-controlled trial, 46 patients with mild to moderate Alzheimer's disease received 30 mg daily of saffron or a placebo. Saffron produced significantly better cognitive outcomes than placebo on the ADAS-cog scale (P = 0.04) and clinical dementia rating (P = 0.04). No significant differences between groups were observed for adverse events.
Akhondzadeh S, Sabet MS, Harirchian MH, et al. J Clin Pharm Ther, 2010. PMID 20831681
2010 / Randomized controlled trial
In a randomized trial, 168 older adults with mild cognitive impairment received daily B vitamins (0.8 mg folic acid, 0.5 mg B12, 20 mg B6) or placebo for 24 months. Brain atrophy averaged 0.76% per year in the active group versus 1.08% with placebo (P = 0.001). The response was greater among individuals with baseline homocysteine above 13 micromol/L, whose atrophy rate dropped by 53% (P = 0.001). Faster atrophy was linked to lower cognitive test scores.
Smith AD, Smith SM, de Jager CA, et al. PLoS One, 2010. PMID 20838622
2010 / Double-blind, multicenter, randomized controlled trial
In the DOMInO trial, 2399 pregnant women were randomized to receive 800 mg/d DHA via fish oil capsules or matched vegetable oil capsules without DHA until birth. High postpartum depressive symptoms occurred in 9.67% of women in the DHA group and 11.19% in the control group (adjusted RR, 0.85; 95% CI, 0.70-1.02; P = .09). Among children followed at 18 months, mean cognitive composite scores (adjusted mean difference, 0.01; 95% CI, -1.36 to 1.37; P = .99) and mean language composite scores (adjusted mean difference, -1.42; 95% CI, -3.07 to 0.22; P = .09) did not differ significantly between groups.
Makrides M, Gibson RA, McPhee AJ, et al. JAMA, 2010. PMID 20959577
2009 / Double-blind, placebo-controlled study
Sixteen healthy participants were evaluated in a double-blind, placebo-controlled study using a gelatin-based protein drink to induce acute tryptophan depletion (ATD). Plasma tryptophan ratio significantly decreased following ATD and did not significantly increase in the placebo condition. Following ATD, delayed recall in the verbal learning test and delayed relocation of objects in the spatial task were impaired, whereas spatial short-term memory improved.
Sambeth A, Riedel WJ, Tillie DE, et al. J Psychopharmacol, 2009. PMID 18515454
2009 / Double-blind, parallel-group, placebo-controlled randomized trial
Thirty Japanese men and women aged 50 to 80 with mild cognitive impairment were randomized to take either Yamabushitake (four 250 mg tablets containing 96% dry powder three times daily) or placebo for 16 weeks, followed by 4 weeks of observation. At weeks 8, 12, and 16, the Yamabushitake group showed significantly increased cognitive function scale scores compared with placebo, with scores increasing with duration of intake. However, scores decreased significantly by 4 weeks after terminating intake. Laboratory tests showed no adverse effects.
Mori K, Inatomi S, Ouchi K, et al. Phytother Res, 2009. PMID 18844328
2009 / Randomized controlled trial
Sixty-two women attempting to lose weight were randomized to four 2-hour mindfulness workshops or a control condition continuing normal diets, with data collected at baseline, 4, and 6 months. At 6 months, intervention participants had significantly greater increases in physical activity versus controls (p<.05), but no significant differences in weight loss or mental health. When excluding participants who reported 'never' applying workshop principles (n=7), the intervention group showed significantly greater increases in physical activity (3.1 sessions per week relative to controls, p<.05) and significantly greater reductions in BMI (0.96 relative to controls, equivalent to 2.32 kg, p<0.5). Reductions in BMI were mediated primarily by reductions in binge eating.
Tapper K, Shaw C, Ilsley J, et al. Appetite, 2009. PMID 19101598
2009 / Randomized, double-blind, placebo-controlled pilot study
In this pilot study, 39 chronic fatigue syndrome patients were randomized to receive either 24 billion colony forming units of Lactobacillus casei strain Shirota (LcS) or a placebo daily for two months. Patients provided stool samples and completed the Beck Depression and Beck Anxiety Inventories before and after treatment. There was a significant rise in both Lactobacillus and Bifidobacteria in the LcS group, along with a significant decrease in anxiety symptoms compared to controls (p = 0.01).
Rao AV, Bested AC, Beaulne TM, et al. Gut Pathog, 2009. PMID 19338686
2009 / Double-blind randomized placebo-controlled trial
A 12-week randomized trial evaluated 93 post-menopausal women receiving either 20 g soy protein with 160 mg total isoflavones or a taste-matched whole milk protein placebo. Eighty-four women completed the study. Women taking isoflavones experienced significant improvements in all four Menopause-specific Quality of Life subscales (vasomotor, psychosexual, physical, and sexual), with no changes in the placebo group. No significant changes occurred within groups for cognition, serum androgens, or plasma lipids, though a group-by-time interaction showed significantly lower total testosterone and HDL levels in the isoflavone group versus placebo at study end.
Basaria S, Wisniewski A, Dupree K, et al. J Endocrinol Invest, 2009. PMID 19411814